Myasthenia Gravis (MG)

Myasthenia Gravis (MG)

Myasthenia Gravis and you

Welcome to the MG area of the J&JWithMe platform, dedicated to helping people understand more about myasthenia gravis (MG).

Receiving a diagnosis of MG can be overwhelming, since the disease can affect not only your physical abilities but also your overall quality of life. MG is characterised by weakness in the voluntary muscles, which are muscles consciously controlled by the brain. Because these muscles are attached to the skeleton throughout the body and control body movement, people living with MG can find daily physical activities challenging. The symptoms of MG are often unpredictable and may fluctuate, which requires adjustments in everyday activities to accommodate the symptoms when living with the disease.

By enhancing understanding of MG, its symptoms and the treatment options available, people living with MG, as well as their carers and loved ones, can play a more active role in care, should they wish. Knowledge and understanding of MG can empower people living with the condition and their caregivers to make informed decisions during medical consultations and to tailor care plans according to specific needs.

Here, we aim to provide trusted and reliable information to help further understanding about the journey of living with MG. More updates are planned for this website, so stay tuned over the coming months. For specific medical advice, always consult your healthcare team as your first point of contact.

Patient Perspective

“My symptoms with myasthenia [MG] can vary from hour to hour, day to day, week to week, month to month. There's no knowing one day how I'm going to feel later on in the same day. I might have reasonably well-controlled symptoms in the morning, but by the evening I may not be able to get up and down the stairs. So, every day is a little bit of its own adventure with symptoms of myasthenia, and there's really no predictability.” – MG Patient, UK

Key topics

About MG
Gain an overview of MG, what it is, what causes it and the path to an MG diagnosis.

References

NHS. Amyloidosis. Accessed May 26, 2022.
McCausland KL, White MK, Guthrie SD, et al. Light chain (AL) amyloidosis: the journey to diagnosis. The Patient-Patient-Centered Outcomes Research. 2018;11(2):207-16.
Cancer.Net. Amyloidosis: Symptoms and Signs. Accessed May 26, 2022.
Mayo Clinic. Amyloidosis overview: symptoms and causes. Accessed May 26, 2022.
National Organization for Rare Disorders. Amyloidosis. Accessed May 26, 2022.
D'Errico S, Mazzanti A, Baldari B, Maiese A, Frati P, Fineschi V. Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists. Int J Clin Exp Pathol. 2020 Jul 1;13(7):1474-1482. PMID: 32782665; PMCID: PMC7414507.
Mayo Clinic. Amyloidosis diagnosis and treatment. Accessed August 20, 2020.
Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy. 2015;32(10):920-928.
Merlini G, Dispenzieri A, Sanchorawala V, et al. Systematic immunglobulin light chain amyloidosis. Nature Review Disease Primers. 2018;4(1):38.
Hasib Sidiqi M, Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. Blood cancer journal. 2021;11(5):1-9.